(Q61915199)

English

Study of NGX267 Oral Capsules in Patients With Xerostomia Associated With Sjorgren's Syndrome

clinical trial

Statements

A Double-Blind, Placebo-Controlled, Cross Over Study Using a Latin Square Design to Evaluate the Safety, Tolerability, and Efficacy of NGX267 Oral Capsules in Patients With Xerostomia Associated With Sjogren's Syndrome (English)
0 references
0 references
0 references
February 2008
0 references
24
0 references
21 year
0 references
55 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit